ReviewTargeted Therapeutics

Improving Treatment of HER2-Positive Cancers: Opportunities and Challenges

See allHide authors and affiliations

Science Translational Medicine  28 Mar 2012:
Vol. 4, Issue 127, pp. 127rv2
DOI: 10.1126/scitranslmed.3001539

Log in to view Figures & Data

Log in through your institution

Log in through your institution